Origin and immunophenotype of aberrant IEL in RCDII patients

Molecular Immunology

Volumn 50, Issue 4, 2012, Pages 262-270

  Tack, Greetje J ^a   van Wanrooij, Roy L J ^a   Langerak, Anton W ^b   Tjon, Jennifer M L ^c   Von Blomberg, Mary B E ^a   Heideman, Danielle A M ^a   Van Bergen, Jeroen ^c   Koning, Frits ^c   Bouma, Gerd ^a   Mulder, Chris J J ^a   Schreurs, Marco W J ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Aberrant lymphocytes; Enteropathy associated T cell lymphoma; Origin; Refractory coeliac disease; T cell receptor

Indexed keywords

GRANZYME B; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

ABERRANT INTRAEPITHELIAL LYMPHOCYTE; ADULT; AGED; ARTICLE; CELIAC DISEASE; CELIAC DISEASE TYPE II; CELL ISOLATION; CELL LINE; CELL MATURATION; CLINICAL ARTICLE; DUODENUM BIOPSY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOCYTE DIFFERENTIATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION; UPREGULATION;

AGED; BLOTTING, SOUTHERN; CELIAC DISEASE; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; GENE REARRANGEMENT, T-LYMPHOCYTE; HUMANS; IMMUNOPHENOTYPING; INTESTINAL MUCOSA; LYMPHOCYTES; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL; SURFACE PLASMON RESONANCE;

EID: 84858334901     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.01.014     Document Type: Article

References (41)

1. Al-Toma A., Goerres M.S., Meijer J.W., et al. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Clin. Gastroenterol. Hepatol. 2006, 4(3):315-319.
2. Al-Toma A., Verbeek W.H., Hadithi M., et al. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut 2007, 56(10):1373-1378.
3. Al-Toma A., Visser O.J., van Roessel H.M., et al. Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells. Blood 2007, 109(5):2243-2249.
4. Bagdi E., Diss T.C., Munson P., et al. Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population. Blood 1999, 94(1):260-264.
5. Bas A., Forsberg G., Sjoberg V., et al. Aberrant extrathymic T cell receptor gene rearrangement in the small intestinal mucosa: a risk factor for coeliac disease?. Gut 2009, 58(2):189-195.
6. Breit T.M., Wolvers-Tettero I.L., Beishuizen A., et al. Southern blot patterns, frequencies, and junctional diversity of T-cell receptor-delta gene rearrangements in acute lymphoblastic leukemia. Blood 1993, 82(10):3063-3074.
7. Cellier C., Patey N., Mauvieux L., et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 1998, 114(3):471-481.
8. Cellier C., Delabesse E., Helmer C., et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. Coeliac Disease Study Group. Lancet 2000, 356(9225):203-208.
9. Cerf-Bensussan N., Azogui O. On the complexity of human CD3- intraepithelial lymphocytes. Gastroenterology 2004, 126(4):1217-1218.
10. Daum S., Weiss D., Hummel M., et al. Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue. Gut 2001, 49(6):804-812.
11. Daum S., Cellier C., Mulder C.J. Refractory coeliac disease. Best Pract. Res. Clin. Gastroenterol. 2005, 19(3):413-424.
12. Daum S., Ipczynski R., Schumann M., et al. High rates of complications and substantial mortality in both types of refractory sprue. Eur. J. Gastroenterol. Hepatol. 2009, 21(1):66-70.
13. Di S.A., Ciccocioppo R., Cupelli F., et al. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 2006, 55(4):469-477.
14. Eiras P., Roldan E., Camarero C., et al. Flow cytometry description of a novel CD3-/CD7+ intraepithelial lymphocyte subset in human duodenal biopsies: potential diagnostic value in coeliac disease. Cytometry 1998, 34(2):95-102.
15. Essers J., Theil A.F., Baldeyron C., et al. Nuclear dynamics of PCNA in DNA replication and repair. Mol. Cell. Biol. 2005, 25(21):9350-9359.
16. Farstad I.N., Johansen F.E., Vlatkovic L., et al. Heterogeneity of intraepithelial lymphocytes in refractory sprue: potential implications of CD30 expression. Gut 2002, 51(3):372-378.
17. Green P.H., Jabri B. Coeliac disease. Lancet 2003, 362(9381):383-391.
18. Hue S., Mention J.J., Monteiro R.C., et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004, 21(3):367-377.
19. Langerak A.W., Wolvers-Tettero I.L., van Dongen J.J. Detection of T cell receptor beta (TCRB) gene rearrangement patterns in T cell malignancies by Southern blot analysis. Leukemia 1999, 13(6):965-974.
20. Lanzini A., Lanzarotto F., Villanacci V., et al. Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet. Aliment. Pharmacol. Ther. 2009, 29(12):1299-1308.
21. Leon F., Roy G. On the complexity of human CD3- intraepithelial lymphocytes. Gastroenterology 2004, 126(4):1217-1218.
22. Malamut G., Afchain P., Verkarre V., et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 2009, 136(1):81-90.
23. Malamut G., El M.R., Montcuquet N., et al. IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis. J. Clin. Invest. 2010, 120(6):2131-2143.
24. Mention J.J., Ben A.M., Begue B., et al. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 2003, 125(3):730-745.
25. Meresse B., Chen Z., Ciszewski C., et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004, 21(3):357-366.
26. Meresse B., Curran S.A., Ciszewski C., et al. Reprogramming of CTLs into natural killer-like cells in celiac disease. J. Exp. Med. 2006, 203(5):1343-1355.
27. Rubio-Tapia A., Murray J.A. Classification and management of refractory coeliac disease. Gut 2010, 59(4):547-557.
28. Rubio-Tapia A., Kelly D.G., Lahr B.D., et al. Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology 2009, 136(1):99-107.
29. Rubio-Tapia A., Rahim M.W., See J.A., et al. Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am. J. Gastroenterol. 2010, 105(6):1412-1420.
30. Stonier S.W., Schluns K.S. Trans-presentation: a novel mechanism regulating IL-15 delivery and responses. Immunol. Lett. 2010, 127(2):85-92.
31. Tack G.J., Verbeek W.H., van de Water J.M., et al. Phenotypic and genomic analysis of an exceptional case of enteropathy associated T-cell lymphoma. Leuk. Res. 2010, 34(8):e183-e189.
32. Tack G.J., Verbeek W.H., Al-Toma A., et al. Evaluation of Cladribine treatment in refractory celiac disease type II. World J. Gastroenterol. 2011, 17(4):506-513.
33. Tjon J.M., Verbeek W.H., Kooy-Winkelaar Y.M., et al. Defective synthesis or association of T-cell receptor chains underlies loss of surface T-cell receptor-CD3 expression in enteropathy-associated T-cell lymphoma. Blood 2008, 112(13):5103-5110.
34. Tjon J.M., van B.J., Koning F. Celiac disease: how complicated can it get?. Immunogenetics 2010, 62(10):641-651.
35. Tjon J.M., Kooy-Winkelaar Y.M., Tack G.J., et al. DNAM-1 mediates epithelial cell-specific cytotoxicity of aberrant intraepithelial lymphocyte lines from refractory celiac disease type II patients. J. Immunol. 2011, 186(11):6304-6312.
36. van Dongen J.J., Langerak A.W., Bruggemann M., et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003, 17(12):2257-2317.
37. Verbeek W.H., Goerres M.S., von Blomberg B.M., et al. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in refractory celiac disease. Clin. Immunol. 2008, 126(1):48-56.
38. Verbeek W.H., von Blomberg B.M., Scholten P.E., et al. The presence of small intestinal intraepithelial gamma/delta T-lymphocytes is inversely correlated with lymphoma development in refractory celiac disease. Am. J. Gastroenterol. 2008, 103(12):3152-3158.
39. Verkarre V., Asnafi V., Lecomte T., et al. Refractory coeliac sprue is a diffuse gastrointestinal disease. Gut 2003, 52(2):205-211.
40. Verkarre V., Romana S.P., Cellier C., et al. Recurrent partial trisomy 1q22-q44 in clonal intraepithelial lymphocytes in refractory celiac sprue. Gastroenterology 2003, 125(1):40-46.
41. WHO classification 2008, 2011. Ref Type: Bill/Resolution.